Johnson Johnson(1)

Published on June 2016 | Categories: Documents | Downloads: 67 | Comments: 0 | Views: 510
of 8
Download PDF   Embed   Report

Comments

Content

J&J

Compiled By
RAKESH KUMAR DASH

MHASKAR IMRAN ANWAR

Placement-Coordinator

PGP-Participant

IIM Indore (PGP-Mumbai)

IIM Indore (PGP-Mumbai)

[email protected]

[email protected]

Johnson-Johnson:-This document is authorized for use only in PGP-Mumbai

J&J: CP
About
Johnson & Johnson (NYSE: JNJ) is an American multinational medical devices, pharmaceutical and
consumer packaged goods manufacturer founded in 1886. Johnson & Johnson consistently ranks at the top
of Harris Interactive's National Corporate Reputation Survey,[2] ranking as the world's most respected
company by Barron's Magazine. Johnson & Johnson's brands include numerous household names of
medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line
of bandages, Tylenol medications, Johnson's baby products, Neutrogena skin and beauty products, Clean &
Clear facial wash and Acuvue contact lenses.
Founded in 1886 in New Brunswick, New Jersey, USA, Johnson & Johnson spread its roots into India in
1947 with the arrival of Mr. Patrick Whaley and in 1948, started marketing Johnson’s Baby Powder which was
manufactured by a local company, British Drug House, in Mumbai. In September 1957, a new company Johnson & Johnson Limited was created and registered with 12 employees on its roll. The company was
licensed to manufacture a broad range of consumer and hospital products. Production began in 1959 from
the earliest Johnson & Johnson plant in Mulund in Mumbai.
Mr. Whaley became the first MD of the company and served for 14 years. The company prospered under his
able leadership. In the years that followed, Johnson & Johnson Limited established a reputation for quality
with a range of products that represented virtually every sector of the company’s business internationally.
The 60s was a decade of manufacturing growth. The first Ethicon plant was set up in Dharavi in Mumbai to
manufacture Catgut sutures. In 1966, the Bhandup plant in Mumbai was set up to manufacture feminine
hygiene products. The Ortho Diagnostics’ manufacturing unit was set up in 1970 and shifted to Deonar in
Mumbai. In 1975, Ethnor Limited (merged with Johnson & Johnson in 1994). set up a plant for
manufacturing pharmaceutical and ethical products of Ortho-McNeil Laboratories and Cilag Chemie. A
second manufacturing plant for personal products started in Bhandup in Mumbai. The state-of-the-art
Ethicon plant in Aurangabad became operational in 1991. The latest addition to the family is the
manufacturing facilities in Baddi in Himachal Pradesh, which caters to both medical and consumer sectors.
Currently, the manufacturing plants are at Baddi (2), Mulund, Aurangabad, Deonar and offices at Mumbai (4),
Chennai, Delhi, Kolkata, a pharma R&D Center in Mulund, a Global Clinical Operations (GCO) office in
Powai, Mumbai, and a Business Knowledge Center in Pune & Bengaluru.
In over 50 years of operating in India, Johnson & Johnson Limited has gained a reputation for delivering
high-quality products.
Today, we employ more than 2000 people and the businesses span Consumer, Medical Devices &
Diagnostics, Pharmaceuticals and Vision Care.

Johnson-Johnson:-This document is authorized for use only in PGP-Mumbai

Johnson & Johnson India has won several Best Employer Awards and is clearly recognized as an employer of
choice. It is also very active in reaching out to those in need through its Corporate Social Responsibility
(CSR) projects.

Brands
Category

Brands

Category

Brands

Baby Care
Women's Sanitary Products
Women's Sanitary Products
Women's Health
Wound Care
Wound Care
Oral Care

Johnson's
Stayfree
Carefree
O.B.
Band Aid
Savlon
Listerine

Skin Care
Skin Care
OTC
OTC
OTC
OTC
OTC

Clean & Clear
Neutrogena
Benadryl
Caladryl
Nicorette
Splenda
Nizoral

Vision & Mission
We believe our first responsibility is to the doctors, nurses and patients, to mothers and fathers and all others
who use our products and services. In meeting our needs everything we do must be of high quality. We must
constantly strive to reduce our costs is order to maintain reasonable prices. Customers’ orders must be
services promptly and accurately. Our suppliers and distributers must have an opportunity to make a fair
profit.
We are responsible to our employees, the men and women who work with us throughout the world.
Everyone must be considered as an individual. We must respect their dignity and recognize their merit. They
must have a sense of security in their jobs. Compensation must be fair and adequate, and working conditions
clean, orderly and safe. We must be mindful, of ways to help our employees fulfill their family responsibilities.
Employees must feel free to make suggestions and complaints. There must be equal opportunity for
employment, development and advancement for those qualified. We must provide competent management;
their actions must be just and ethical.
We are responsible to the communities in which we live and work and to the world community as well. We
must be good citizens – support good works and charities and bear our fair share of taxes. We must
encourage civic improvements and better health and education. We must maintain in good order the property
we are privileged to use, protecting the environment and natural resources.
Our final responsibility is to our stakeholders. Business must make a sound profit. We must experiment with
new ideas. Research must be carried on, innovative programs developed and mistakes paid for. New
equipment must be purchased, new facilities provided and new products launched. Reserves must be created
to provide for adverse times. When we operate according to these principles, the stockholders should realize
a fair return.

Johnson-Johnson:-This document is authorized for use only in PGP-Mumbai

• Product

• People

Patients,
Doctors

Employees

Commitment

Shareholders

• Profit

Society

• Planet

News
2 Nov 2011 - Two chemicals considered harmful to babies remain Johnson’s baby shampoo sold in
the US and some even though the company already makes versions according to an international
coalition of health and groups.
23 March 2012 - Johnson & (J&J) India will reduce its dependence on its near-generic Johnson's baby care
range of products that makes up for half its revenues, and focus more on feminine hygiene, skin-care and
over-the-counter (OTC) items.
12 May 2012 - Janssen-Cilag, a division of Johnson & Johnson Ltd. India, has announced the launch of
Nizoral™ 100ml bottles in the Indian market. Nizoral™, a clinically proven dandruff treatment shampoo, is
now avai lable to the consumers for Rs 185. Nizoral contains Ketoconazole, a potent ingredient used in the
treatment of dandruff. Ketoconazole is an original research molecule of Janssen–Cilag which ensures long
lasting relief from dandruff.
27 July 2012 - Johnson & Johnson Medical is looking to acquire medical device makers in India and China in
the areas of trauma care, infection prevention and diagnostics.
22 Aug 2012 - Johnson & Johnson (JNJ), which faces about 8,000 lawsuits over hip implants it recalled in
2010, agreed to pay about $600,000 to resolve three cases in the first settlements of the litigation, people
familiar with the accords said.

Johnson-Johnson:-This document is authorized for use only in PGP-Mumbai

31 Aug 2012 - Johnson & Johnson (JNJ) will pay $181 million to resolve claims by 36 states that it improperly
marketed and advertised the antipsychotic drugs Risperdal and Invega.
11 Sept 2012 - Industry giant Johnson & Johnson made a stunning announcement: it was prepared to
eliminate a “most wanted” list of chemicals from its beauty and baby products lines by 2015.
30 Nov 2012 - CEO Alex Gorsky Elected Chairman of Johnson & Johnson. Bill Weldon to Step down after
41-year Career at Johnson & Johnson
7 Jan 2013 - Sanofi unit acquires Rolaids from J&J.
6 Jun 2013 - Advertising industry watchdog ASCI today said it has upheld 52 complaints against companies,
including Procter & Gamble, HUL, Honda, Johnson & Johnson and Dabur , for violating guidelines in
March this year.
18 Jul 2013 - JB Chemicals & Pharmaceuticals today said it has reached a settlement with Cilag GmbH
International and Johnson & Johnson LLC entities regarding all claims raised by them in relation to sale of its
over-the- counter business in Russia and CIS countries
3 Oct 2013 - The packaging seal used by four multinational companies came under the spotlight after a public
interest litigation (PIL) filed in the Bombay High Court highlighted the use of improper sealing methods,
which could be potentially hazardous for consumers.
7 Jan 2014 - Speaking at the 51st Annual National Conference of the Indian Academy of Pediatrics, Neeraj
Goyal, General Marketing Manager, Women's Health Franchise, Johnson & Johnson, said “Newborn care
and Resuscitation is the prime focus of Johnson & Johnson and Neonatal resuscitation Program is a big leap
to ensure that the world’s youngest citizens get the best possible start in life. The NRP program has set an
ambitious target of training 50,000 healthcare professionals in Basic Newborn Care and Resuscitation across
50 high impact districts of the country. The aim of the initiative is to have at least one person trained in basic
newborn care and resuscitation at every delivery.”
23 Jan 2014 - Nicorette® (tobacco cessation chewing gum) organized a conference to highlight the need and
effectiveness of a solid tobacco cessation infrastructure to help tobacco users overcome their addiction. The
conference highlighted the fact that according to the Global Adult Tobacco Survey (GATS Survey, 2010),
there are 275 million tobacco users in India.
9 May 2014 - Johnson’s® Baby announces the launch of its ‘Share the Language of Love’ campaign aimed at
helping less-fortunate children experience the joys of childhood. Goonj, India’s leading NGO has partnered
with Johnson’s Baby since the campaign first rolled-out in 2012 and will continue to play a crucial role in
ensuring that the contributions reach the recipients safely.
16 Sep 2014 - Global pharmaceuticals and consumer packaged goods manufacturer Johnson and Johnson's
biggest manufacturing facility in India is set to come up in Telangana with an investment of Rs.400 crore.
1 Oct 2014 - Johnson & Johnson agreed to pay $1.75 billion in cash to buy privately held Alios BioPharma
Inc, which is developing a drug for a common respiratory viral infection in children for which there is no
approved treatment.

Johnson-Johnson:-This document is authorized for use only in PGP-Mumbai

14 Oct 2014 - Johnson & Johnson reported strong quarterly earnings, boosted by surging sales of a new drug
for hepatitis C that are expected to evaporate in coming months due to competition from a more potent and
convenient combination treatment.
22 Oct 2014 - Johnson & Johnson is accelerating work on its experimental Ebola vaccine and aims to
produce 1 million doses next year, 250,000 of which are expected to be available by May.

Johnson-Johnson:-This document is authorized for use only in PGP-Mumbai

Johnson-Johnson:-This document is authorized for use only in PGP-Mumbai

Johnson-Johnson:-This document is authorized for use only in PGP-Mumbai

Sponsor Documents

Or use your account on DocShare.tips

Hide

Forgot your password?

Or register your new account on DocShare.tips

Hide

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close